Tobramycin

4 trials 3 recruiting JAnti-infectives

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

3 Recruiting

0 Completed trials

4 Sponsors

3 Countries

Phase III

Phase IV

Phase III: 1 Phase IV: 3

Indications tested

Sponsors using this IMP

Consorci Mar Parc De Salut De Barcelona 1 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla 1 Medivis S.r.l. 1 Region Hovedstaden 1

All trials

4 total

PHARMACOLOGICAL STRATEGIES OF INHALED ANTIBIOTHERAPY IN BRONCHIECTASIS WITH CHRONIC BRONCHIAL INFECTION: BRONCHIPHARMA STUDY. Pending

2023-510220-72-00 Phase IV 1 country Consorci Mar Parc De Salut De Barcelona
Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia produced by Pseudomonas aeruginosa: a multicenter, randomized… Recruiting

2023-508441-41-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
Effect of nepafenac/dexamethasone fixed dose combination vs. its individual components (nepafenac and dexamethasone monotherapies) on postop… Recruiting

2025-523367-38-00 Phase III 1 country Medivis S.r.l.
Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study Recruiting

2024-514900-16-00 Phase IV 1 country Region Hovedstaden

Showing 1–4 of 4 trials

← All drugs A–Z